The author of that call, Oppenheimer Asset Management’s chief investment strategist, John Stoltzfus, has bested Deutsche Bank’s current top forecast of 7,000, which is also held by Yardeni ...

We express our gratitude and look forward to good times ahead in both Highland and St. John." Michels featured a large bar, many televisions showing sports and an American pub menu that included ...

Her work previously appeared in Newsweek. Mediapunch/Shutterstock While John Lennon might have been one of the biggest rock stars in history to his adoring fans around the world, to his sons ...

Editas Medicine said Thursday afternoon it will lay off 65% of its staff — around 180 employees — as it shelves its lead gene-editing program for sickle cell disease and shifts focus.

Another round of layoffs at John Deere is coming to Iowa. This time, 112 workers will be laid off from the East Donald Street plant in Waterloo by Jan. 6, while another 80 will be laid off at the ...

John Deere has announced that farmers are cutting annual herbicide costs by nearly 60% on average with its See & Spray technology. Back in September, John Deere released some interesting stats ...

The dual Wiz and ZBTB7A degrader entered into a first Phase 1/2 sickle cell disease trial in July, 1 month ahead of a similar compound from Novartis. “It’s a super exciting molecule and a ...

Mahama returns after two failed attempts He campaigned on promise to "reset Ghana" He plans to renogotiate terms of IMF bailout ACCRA, Dec 9 (Reuters) - John Dramani Mahama, who is returning as ...

SAN DIEGO — Pfizer’s abrupt withdrawal of its sickle cell drug Oxybryta over safety concerns was called “tone deaf” during a panel discussion among sickle cell experts Saturday at STAT@ASH ...

Though he doesn't remember it, Branden Baptiste had his first sickle cell crisis at age 2. Through elementary school, he was in and out of the hospital with pain episodes, not knowing why.

Two FDA-approved gene therapies, Lyfgenia and Casgevy, will be offered through an outcomes-based Medicaid model launching in January 2025. The initiative ties payments to treatment effectiveness ...